scPharmaceuticals
SCPH
SCPH was delisted on the 6th of October, 2025.
33 hedge funds and large institutions have $92.4M invested in scPharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
47% more capital invested
Capital invested by funds: $62.9M → $92.4M (+$29.5M)
22% more funds holding
Funds holding: 27 → 33 (+6)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.18% less ownership
Funds ownership: 59.7% → 59.53% (-0.18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$7.79M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.97M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$837K |
| 4 |
Millennium Management
New York
|
+$254K |
| 5 |
Renaissance Technologies
New York
|
+$209K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EP
Eversept Partners
New York
|
-$1.23M |
| 2 |
Squarepoint
New York
|
-$239K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$101K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$88.2K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$68.9K |
SCPH Hedge Fund Activity: Q1 2020 in Review
33 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in scPharmaceuticals (SCPH) for Q1 2020, worth a combined $92.4M — up 47% from $62.9M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new SCPH positions and 5 closed out — a net gain of 7 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $7.79M. The largest seller was Eversept Partners, cutting an estimated $1.23M.
- 33 institutional investors held scPharmaceuticals (SCPH) as of Q1 2020, up from 27 in Q4 2019.
- Funds reported $92.4M of scPharmaceuticals stock for Q1 2020, up 47% quarter-over-quarter.
- 12 funds opened new scPharmaceuticals positions in Q1 2020 and 5 closed out, a net change of +7 holders.
- The largest scPharmaceuticals buyer in Q1 2020 was Ikarian Capital, an estimated $7.79M added.
- The largest scPharmaceuticals seller in Q1 2020 was Eversept Partners, an estimated $1.23M sold.
Based on aggregated 13F filings for Q1 2020.